Home

Pfizer, Inc. - Financial Overview

Ticker - PFE

Close PriceMarket CapP/E RatioForward P/E RatioImplied Growth*Implied Forward Growth*P/B Ratio
$23.35$132.75B16.98.09.9%2.3%1.5

Revenue and Net Income Chart EPS Chart
  Date Revenue Net Income EPS Revenue Change Net Income Change EPS Change
0 2020-12-31 $41.7B $9.2B $1.73 N/A N/A N/A
1 2021-12-31 $81.3B $22.0B $3.92 95.2% 140.0% 126.6%
2 2022-12-31 $100.3B $31.4B $5.59 23.4% 42.7% 42.6%
3 2023-12-31 $58.5B $2.1B $0.38 -41.7% -93.2% -93.2%
4 2024-12-31 $63.6B $8.0B $0.38 8.8% 279.0% 0.0%
5 TTM 2025-03-31 $62.5B $7.9B $1.38 -1.8% -1.8% 263.2%
6 Average 16.8% 73.3% 67.8%




PFE - Forecast Data



PFE - Y/Y % Change

  Metric Value
0 Total Assets $208,028M
1 Cash $1,430M
2 Total Liabilities $117,391M
3 Total Debt $61,291M
4 Total Equity $90,338M
5 Debt to Equity Ratio 0.68
PFE Balance Sheet Chart


PFE - Expense Overview



PFE - Unmapped Expense Line Items

No unmapped expenses.



PFE - Valuation Chart


Valuation Chart

Share Price Treasury Yield Estimates Fair Value (P/E) Fair Value (P/S) Current P/S Current P/E
$23.35 4.5% Nicks Growth: 2%
Nick's Expected Margin: 10%
FINVIZ Growth: -0%
Nicks: 8
Finviz: 6
Nick's: 0.776 2.1 16.9
Basis Year Nicks Valuation Nicks vs Share Price Finviz Valuation Finviz vs Share Price
$1.38 EPS TTM $10.70 -54.2% $8.46 -63.8%
$3.06 EPS 2025 $23.73 1.6% $18.75 -19.7%
$3.09 EPS 2026 $23.96 2.6% $18.93 -18.9%